Tatva chintan pharma Chem Limited has announced its upcoming investor engagement schedule, informing stock exchanges about a planned meeting with OysterRock Capital. The pharmaceutical company submitted this disclosure to BSE Limited and National Stock Exchange of India Limited on March 19, 2026, in compliance with regulatory requirements.

Meeting Details

The company has scheduled a virtual investor interaction with specific parameters outlined for transparency and regulatory compliance.

Regulatory Compliance and Information Sharing

Tatva Chintan Pharma Chem Limited has emphasized its commitment to maintaining regulatory standards during the investor interaction. The company has clearly stated that discussions will be limited to publicly available information only. No confidential or unpublished price sensitive information (UPSI) will be shared during the meeting, ensuring compliance with SEBI guidelines.

The company has also noted that the meeting schedule is subject to change if required. All relevant information regarding this investor interaction will be made available on the company's official website at www.tatvachintan.com for public access.

Corporate Communication

The disclosure was signed by Ishwar Nayi, Company Secretary and Compliance Officer, with membership number A37444. The communication was formally submitted to both major stock exchanges where the company is listed, maintaining transparency in corporate governance practices. This proactive disclosure demonstrates the company's adherence to SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended.

Tatva Chintan Pharma Chem Limited has informed stock exchanges about significant changes to its natural gas supply arrangements following the implementation of the Natural Gas Supply Regulation Order 2026. The pharmaceutical and specialty chemicals manufacturer received communication from Gujarat Gas Limited on 13 March 2026 regarding the new regulatory framework that will impact its manufacturing operations while actively seeking alternative fuel options.

Regulatory Changes and Supply Restrictions

The Natural Gas Supply Regulation Order 2026, issued by the Ministry of Petroleum and Natural Gas on 09 March 2026 under the Essential Commodities Act 1955, introduces substantial changes to gas allocation and pricing mechanisms. The order was implemented as a response to geopolitical conflicts in the Middle East that have disrupted natural gas availability.

Under the new framework, gas supply to industrial consumers, including Tatva Chintan's manufacturing facilities, will be maintained at 80% of the past six months' average gas consumption, subject to operational availability. The supply and allocation will be governed by a pooled price mechanism as notified by the Petroleum Planning & Analysis Cell (PPAC), which will determine the final retail sale price for the company's units.

Impact on Operations and Mitigation Measures

The government mandate supersedes existing provisions of the company's Gas Sales Agreement regarding both pricing and contract quantities. This regulatory change affects the fundamental terms under which Tatva Chintan has been operating its gas-dependent manufacturing processes.

To address these challenges, the company has implemented several mitigation strategies:

• Arranged alternative fuel sources as permitted by Gujarat Pollution Control Board (GPCB)
• Optimized production processes to minimize impact on output
• Established monitoring systems to track developments

Financial Implications and Outlook

While Tatva Chintan has acknowledged that the potential financial impact of the gas shortage and revised pricing mechanism cannot be fully quantified at this stage, the company is actively monitoring the situation. The pooled pricing mechanism introduced by PPAC may result in different cost structures compared to the previous gas sales agreement terms.

The company has committed to keeping stock exchanges informed of any material updates as the situation develops. This proactive disclosure approach demonstrates the company's commitment to maintaining transparency with stakeholders regarding operational challenges that may affect business performance.

Regulatory Compliance and Communication

Tatva Chintan's disclosure was made pursuant to Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements Regulations 2015. The company secretary and compliance officer, Ishwar Nayi, signed the communication on 14 March 2026, ensuring timely compliance with regulatory requirements. The information has been made available on the company's website at www.tatvachintan.com for stakeholder access.